Drug recall · April 26, 2023
Aripiprazole Tablets recall
Why: Out of specification (OOS) for Spectroscopic Identification test by IR.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05
- Lots / codes
Lot #22143120, Exp. Date: June 2024
- Quantity
- 135 bottles
- Company
- Ascend Laboratories, LLC, Parsippany, NJ
- Distribution
- Nationwide in the USA
- Initiated
- March 17, 2023 · Voluntary: Firm initiated
- Classified
- April 19, 2023
- Reported
- April 26, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.